CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes

Neutral
AI Analysis

Summary

Journey Medical (DERM) received updated price target assessments from Fortress following changes to its valuation model. No specific clinical, regulatory, or financial details are provided in the headline.

Importance:3/10
Sentiment:
0.00
valuationprice targetanalyst update
Related Companies

Read the original article

Published by yahoo_finance on June 25, 2026 4:29 AM

Read Original